Form 4: uniQure CFO Sells Shares After Option Exercise

uniQure N.V.'s Chief Financial Officer, Christian Klemt, executed and sold a total of 18,000 ordinary shares in two separate transactions in late September 2025, pursuant to a pre-arranged 10b5-1 trading plan.

Summary

• Christian Klemt, Chief Financial Officer of uniQure N.V. (QURE), reported transactions involving the exercise of stock options and subsequent sale of ordinary shares.
• On September 24, 2025, Klemt exercised options to acquire 3,000 ordinary shares at an exercise price of $13.03 per share.
• Immediately following the exercise on September 24, 2025, Klemt sold these 3,000 ordinary shares at a weighted average price of $40.04 per share, with individual sales ranging from $40.00 to $40.15.
• On September 26, 2025, Klemt exercised options to acquire 15,000 ordinary shares at an exercise price of $5.37 per share.
• Immediately following the exercise on September 26, 2025, Klemt sold these 15,000 ordinary shares at a weighted average price of $55.00 per share, with individual sales ranging from $55.00 to $55.02.
• All reported transactions were effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on January 13, 2025.
• Following these transactions, Christian Klemt's direct beneficial ownership of uniQure N.V. ordinary shares stands at 217,730.

Sentiment

Score: 6

Explanation: The sentiment is slightly positive due to the significant gains realized from the option exercises and sales, indicating favorable stock performance. However, the overall sentiment remains largely neutral as these are routine insider transactions executed under a pre-arranged plan, which is a common practice for executive compensation.

Positives

• The significant difference between the option exercise prices ($13.03 and $5.37) and the sale prices ($40.04 and $55.00) indicates substantial appreciation in uniQure N.V.'s stock value, reflecting positively on the company's performance over the vesting periods.
• The transactions were conducted under a pre-arranged Rule 10b5-1 plan, which demonstrates a structured and pre-scheduled approach to insider stock sales, mitigating concerns about opportunistic trading based on non-public information.

Negatives

• The sale of shares by a Chief Financial Officer, even under a 10b5-1 plan, could be interpreted by some investors as a signal of an executive realizing gains rather than holding for future appreciation, though this is a common practice for executive compensation and diversification.

Future Outlook

This Form 4 filing reports past insider transactions and does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

This filing details routine insider stock transactions and does not provide information directly related to broader industry trends or competitive landscape for uniQure N.V.

Stakeholder Impact

• Shareholders: May view the CFO's realization of significant gains as a positive indicator of past stock performance, while the sale itself, being under a 10b5-1 plan, is generally not considered a negative signal regarding future prospects.
• Employees: No direct impact on employees is indicated by this filing.
• Customers, Suppliers, Creditors: No direct impact on these stakeholders is indicated by this filing.

Key Dates

Keywords

uniQure N.V., QURE, Christian Klemt, CFO, Insider Trading, Form 4, Stock Options, Share Sale, 10b5-1 Plan, Executive Compensation